Showing results (1081-1090 of 1,196) with videos related to

Sort By:
Pageof 120
JACC. Heart Failure|March 14, 2014
Adrenergic activation, fuel substrate availability, and insulin resistance in patients with congestive heart failureNir Uriel, Jose Gonzalez-Costello, Andrea Mignatti, et al.
JACC. Heart Failure|March 14, 2014
Urocortin-2 infusion in acute decompensated heart failure: findings from the UNICORN study (urocortin-2 in the treatment of acute heart failure as an adjunct over conventional therapy)W Y Wandy Chan, Christopher M Frampton, Ian G Crozier, et al.
JACC. Heart Failure|March 14, 2014
Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathyYuichi J Shimada, Jonathan J Passeri, Aaron L Baggish, et al.
JACC. Heart Failure|March 14, 2014
Clinical outcomes and cardiovascular responses to different exercise training intensities in patients with heart failure: a systematic review and meta-analysisHashbullah Ismail, James R McFarlane, A Hadi Nojoumian, et al.
JACC. Heart Failure|March 14, 2014
Antiplatelet and anticoagulant agents in heart failure: current status and future perspectivesPaul A Gurbel, Udaya S Tantry
JACC. Heart Failure|March 14, 2014
Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failureHanna K Gaggin, Jackie Szymonifka, Anju Bhardwaj, et al.
JACC. Heart Failure|March 14, 2014
Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b)Barry Greenberg, Alex Yaroshinsky, Krisztina M Zsebo, et al.
JACC. Heart Failure|April 12, 2014
Developing therapies for heart failure with preserved ejection fraction: current state and future directionsJaved Butler, Gregg C Fonarow, Michael R Zile, et al.
JACC. Heart Failure|April 12, 2014
Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fractionMichael R Zile, Robert C Bourge, Margaret M Redfield, et al.
JACC. Heart Failure|April 12, 2014
Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist deviceAnna L Meyer, Doris Malehsa, Ulrich Budde, et al.
Pageof 120